πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 88 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6933274

Methods for treatment of diabetes using a peptide analogues of insulin

Neurocrine Biosciences, Inc. Β· Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6890518

Compositions of chemically modified insulin

Nektar Therapeutics Β· Granted Tue May 10 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6838076

Pulmonary administration of chemically modified insulin

Nektar Therapeutics Β· Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6770276

Insulin-containing medicament for peroral application and method for the production thereo

Otkrytoe Aktsionernoe Obschestvo ΓƒΒ’Γ’β€šΒ¬Γ…β€œQuantum SatisΓƒΒ’Γ’β€šΒ¬Γ‚Β Β· Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6737045

Methods and compositions for the pulmonary delivery insulin

Nektar Therapeutics Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685967

Methods and compositions for pulmonary delivery of insulin

Nektar Therapeutics Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6562942

Methods for treatment of diabetes using peptide analogues of insulin

Neurocrine Biosciences, Inc. Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6511811

Protein kinase C antagonist related to insulin receptor

The Regents of the University of California Β· Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6468959

Peroral dosage form for peptide containing medicaments, in particular insulin

ALFATEC-Pharm GmbH Β· Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6448045

Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1

The Regents of the University of California Β· Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6391651

Materials and methods for detection of insulin dependent diabetes

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6319495

Method for restoring glucose responsiveness to insulin secretion

The Regents of the University of California Β· Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6207159

Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

The Regents of the University of California Β· Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6197926

Methods for treatment of diabetes using peptide analogues of insulin

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6071891

Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells compositio

Regents of the University of Minnesota Β· Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6022697

Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

The Regents of the University of California Β· Granted Tue Feb 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired